Thymoquinone Inhibits Bone Metastasis of Breast Cancer Cells Through Abrogation of the CXCR4 Signaling Axis

• Main Authors: Shanmugam, Muthu K, Ahn, Kwang Seok, Hsu, Annie, Woo, Chern Chiuh, Yuan, Yi, Tan, Kwong Huat Benny, Chinnathambi, Arunachalam, Alahmadi, Tahani Awad, Alharbi, Sulaiman Ali, Koh, Angele Pei Fern, Arfuso, Frank, Huang, Ruby Yun-Ju, Lim, Lina HK, Alan, Gautam Sethi, Kumar, Alan Prem
• Other Authors: PHARMACOLOGY
• Format: Article
• Language: English
• Published: FRONTIERS MEDIA SA 2022
• Subjects: Science & Technology; Life Sciences & Biomedicine; Pharmacology & Pharmacy; breast cancer; metastasis; thymoquinone; chemokine receptor 4; preclinical "in vivo" study; NF-KAPPA-B; CHEMOKINE RECEPTOR CXCR4; HUMAN HEPATOCELLULAR-CARCINOMA; EMERGING TARGETED THERAPIES; OXIDATIVE STRESS; TUMOR-GROWTH; TRANSGENIC ADENOCARCINOMA; TRANSCRIPTION FACTORS; POTENTIAL ROLE; MURINE MODELS
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/219262
• Institution: National University of Singapore

10.3389/fphar.2018.01294